Literature DB >> 9450840

Management of cancer in the elderly: therapeutic dilemmas.

M Hirano1, K Mori.   

Abstract

As the average life span has increased, the number of elderly patients with cancer has increased. One of the greatest dilemmas in the management of cancer in the elderly is the fact that often regular curative treatment cannot be executed. From this viewpoint, 679 patients with head and neck cancer treated during a recent 5-year period were reviewed. They were classified into two age groups: those younger than 75 years (n = 560) and those 75 years and older (n = 119). The frequency with which curative treatment could not be executed was 8.8% in the younger group and 26.1% in the older group. The major reasons were concomitant health problems and failure to obtain the patient's consent, and these problems were significantly more common in the older group. The incidence of asthma, pulmonary emphysema, cardiac failure, hypertension, arrhythmia, cerebrovascular disease, and kidney failure was greater in the older group. The overall 3-year survival rate was 18% in the cases with no curative treatment and 77% in those curatively treated.

Entities:  

Mesh:

Year:  1998        PMID: 9450840     DOI: 10.1016/S0194-5998(98)70386-9

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  9 in total

1.  Treatment of head and neck cancer in the elderly: European Consensus (panel 6) at the EUFOS Congress in Vienna 2007.

Authors:  Reidar Grénman; Dominique Chevalier; Vincent Gregoire; Eugene Myers; Simon Rogers
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-05-09       Impact factor: 2.503

2.  Age and stage as determinants of treatment for oral cavity and oropharyngeal cancers in the elderly.

Authors:  David Goldenberg; Heath Mackley; Wayne Koch; Darrin V Bann; Eric W Schaefer; Christopher S Hollenbeak
Journal:  Oral Oncol       Date:  2014-08-19       Impact factor: 5.337

3.  The effect of age on survival and quality of life in elderly head and neck cancer patients: a long-term prospective study.

Authors:  Marc P van der Schroeff; Wynia Derks; Gerrit Jan Hordijk; Rob J de Leeuw
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-11-11       Impact factor: 2.503

4.  Free flap reconstruction for head and neck cancer can be safely performed in both young and elderly patients after careful patient selection.

Authors:  Thomas T A Peters; Sophie F Post; Boukje A C van Dijk; Jan L N Roodenburg; Bernard F A M van der Laan; Paul M N Werker; Gyorgy B Halmos
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-13       Impact factor: 2.503

5.  Reasons for non-standard treatment in elderly patients with advanced head and neck cancer.

Authors:  W Derks; J R J de Leeuw; G J Hordijk; J A M Winnubst
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-03-11       Impact factor: 2.503

6.  Laser surgery of early glottic cancer in elderly.

Authors:  M Ansarin; A Cattaneo; L Santoro; M A Massaro; S F Zorzi; E Grosso; L Preda; D Alterio
Journal:  Acta Otorhinolaryngol Ital       Date:  2010-08       Impact factor: 2.124

7.  Factors pertaining to long-term mortality following emergency visits for head and neck cancer.

Authors:  Pei-Ling Tang; Hung-Chih Chen; Wei-Chun Huang; Shuo-Fang Li; Hsiao-Ching Kuo
Journal:  J Dent Sci       Date:  2018-05-31       Impact factor: 2.080

8.  Management Practices of Head and Neck Cancer in Chinese Tertiary Care Hospitals: A Multicenter Questionnaire-Based Survey Among Oncologists.

Authors:  Zhao Anwei; Sun Xin; Tang Qiao Fei; Jin Ziyu; Fa-Yu Liu
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302

9.  Chemoradiotherapy as Definitive Treatment for Elderly Patients with Head and Neck Cancer.

Authors:  Jens Müller von der Grün; Daniel Martin; Timo Stöver; Shahram Ghanaati; Claus Rödel; Panagiotis Balermpas
Journal:  Biomed Res Int       Date:  2018-01-17       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.